Table 5 Correlation of steatosis degree with LI-RADS major and ancillary HCC features
Steatosis grade | Hepatic fat fraction % | |||
|---|---|---|---|---|
r | P* | r | P* | |
Major HCC features | ||||
Non-peripheral “washout” | − 0.169 | 0.268 | − 0.186 | 0.220 |
Enhancing “capsule” | − 0.441 | 0.002 | − 0.219 | 0.149 |
Size (mm) | − 0.331 | 0.026 | − 0.264 | 0.080 |
Threshold growth | − 0.093 | 0.543 | 0.072 | 0.640 |
Ancillary features favoring malignancy | ||||
Corona enhancement | − 0.151 | 0.322 | − 0.206 | 0.175 |
Subthreshold growth | 0.052 | 0.733 | − 0.012 | 0.936 |
Mild–moderate T2 hyperintensity | − 0.454 | 0.002 | − 0.370 | 0.012 |
Restricted diffusion | − 0.308 | 0.039 | − 0.327 | 0.029 |
Fat sparing in solid mass | 0.153 | 0.317 | 0.060 | 0.696 |
Ancillary features favoring HCC | ||||
Non-enhancing “capsule” | 0.164 | 0.282 | 0.038 | 0.805 |
Nodule-in-nodule architecture | − 0.122 | 0.425 | − 0.008 | 0.957 |
Mosaic architecture | − 0.151 | 0.322 | 0.021 | 0.893 |
Fat in mass, more than adjacent liver | − 0.107 | 0.483 | − 0.033 | 0.829 |
Blood products in mass | − 0.085 | 0.578 | 0.093 | 0.544 |